| Title : Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive\/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS\/AFT-05\/ABCSG-42\/BIG-14-03) - Mayer_2022_J.Clin.Oncol__JCO2101918 |
| Author(s) : Mayer EL , Fesl C , Hlauschek D , Garcia-Estevez L , Burstein HJ , Zdenkowski N , Wette V , Miller KD , Balic M , Mayer IA , Cameron D , Winer EP , Ponce Lorenzo JJ , Lake D , Pristauz-Telsnigg G , Haddad TC , Shepherd L , Iwata H , Goetz M , Cardoso F , Traina TA , Sabanathan D , Breitenstein U , Ackerl K , Metzger Filho O , Zehetner K , Solomon K , El-Abed S , Theall KP , Lu DR , Dueck A , Gnant M , DeMichele A |
| Ref : J Clin Oncol , :JCO2101918 , 2022 |
| PubMedID: 34995105 |